Full Press Release Details
ABBOTT PARK, Ill., July 28, 2014 /PRNewswire/ -- Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT ) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 27 through July 31, 2014 , in Chicago.
"Abbott is designing the next generation of diagnostics solutions to help health care providers achieve faster and more accurate test results," said Brian Blaser , executive vice president, Diagnostics Products, Abbott. "Abbott is focused on providing an integrated diagnostic solution, powered by innovations that can help our customers channel change into growth and ensure exceptional performance."
During the AACC meeting, Abbott will feature a variety of innovations focused on increased testing volumes and improving efficiencies:
Scientific Presentations and Posters
During the AACC program, Abbott will present more than 40 scientific presentations and/or posters related to the company's solutions. A complete list of Abbott's presentations, posters and workshops can be found at www.abbottdiagnostics.com .
About Abbott Diagnostics
Abbott is a global health care company devoted to improving life through the development of products and technologies that span the breadth of health care. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.